1.
Bioorg Med Chem Lett
; 12(21): 3219-22, 2002 Nov 04.
Article
in English
| MEDLINE
| ID: mdl-12372538
ABSTRACT
The ultrashort-acting benzodiazepine (USA BZD) agonists reported previously have been structurally modified to improve aqueous solubility. Lactam-to-amidine modifications, replacement of the C5-haloaryl ring, and annulation of heterocycles are presented. These analogues retain BZD receptor potency and full agonism profiles.